The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Sharlai A.S.

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology

Volchkov E.V.

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology

Abramov D.S.

Dmitry Rogachev National Medical Research Center of pediatric hematology, oncology and immunology

Sidorov I.V.

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology

Baranova M.A.

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology

Myakova N.V.

Dmitry Rogachev National Medical Research Center of pediatric hematology, oncology and immunology

Konovalov D.M.

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology;
Russian Medical Academy for Continuous Professional Education

An improved algorithm for genetic diagnostics of aggressive B-cell lymphomas in pediatric oncohematology: the experience of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology

Authors:

Sharlai A.S., Volchkov E.V., Abramov D.S., Sidorov I.V., Baranova M.A., Myakova N.V., Konovalov D.M.

More about the authors

Read: 957 times


To cite this article:

Sharlai AS, Volchkov EV, Abramov DS, Sidorov IV, Baranova MA, Myakova NV, Konovalov DM. An improved algorithm for genetic diagnostics of aggressive B-cell lymphomas in pediatric oncohematology: the experience of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. Russian Journal of Archive of Pathology. 2026;88(1):5‑10. (In Russ.)
https://doi.org/10.17116/patol2026880115

Recommended articles:
Primary lymphoma of the central nervous system. Russian Journal of Archive of Pathology. 2025;(6):56-60
Primary cuta­neous diffuse large B-cell lymphoma, leg type. P.A. Herzen Journal of Onco­logy. 2026;(3):73-78

References:

  1. WHO Classification of Tumours Editorial Board. Haematolymphoid tumours. International Agency for Research on Cancer. WHO classification of tumours series, 5th ed.; vol. 11. France, Lyon: IARC; 2024. https://tumourclassification.iarc.who.int/chapters/63
  2. Alaggio R, Amador C, Anagnostopoulos I. et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36: 1720-1748.
  3. Laurence de Leval, Ash A. Alizadeh, P. Leif Bergsagel et al; Genomic profiling for clinical decision making in lymphoid neoplasms. Blood. 2022; 140 (21): 2193-2227. https://doi.org/10.1182/blood.2022015854
  4. Mussolin L, Pillon M, d’Amore ES, Conter V, Piglione M, Lo Nigro L, Garaventa A, Buffardi S, Aricò M, Rosolen A. Minimal disseminated disease in high-risk Burkitt’s lymphoma identifies patients with different prognosis. J Clin Oncol. 2011;29(13):1779-84. 
  5. Newman AM, Zaka M, Zhou,P. et al. Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma. Leukemia. 2022; 36:781-789.  https://doi.org/10.1038/s41375-021-01444-6
  6. Volchkov EV, Abugova YG, Brenning KR, Abramov DS, Fominykh VV, Senchenko MA, Chugaeva LK, Olshanskaya YV, Novichkova GA, Myakova NV. The prognostic value of TP53 mutational status in children with Burkitt lymphoma treated according to the B-NHL-2010M protocol. Pediatric Hematology/Oncology and Immunopathology. 2024;23(1):56-62. (in Russ.). https://doi.org/10.24287/1726-1708-2024-23-1-56-62
  7. Volchkov EV. Abugova YG, Mamedov IZ, Abramov DS, Senchenko MA, Anderzhanova LK, Komkov AY, Fominykh VV. Olshanskaya YV, Myakova NV, Novichkova GA. The evaluation of minimal disseminated disease in the bone marrow of children with Burkitt lymphoma using next generation sequencing. Pediatric Hematology/Oncology and Immunopathology. 2023;22(1):32-38. (in Russ.). https://doi.org/10.24287/1726-1708-2023-22-1-32-38
  8. Martire G, Lovisa F, Carraro E, Rizzato D, Cesaro S, Mura RM, Tondo A, Bertolin C, Boaretto F, Salviati L, Biffi A, Pillon M, Mussolin L. <i>TP53</i&gt; DNA binding domain mutational status and rituximabbased treatment are independent prognostic factors for pediatric Burkitt lymphoma patients stratification. Haematologica. 2024;109(9):3031-3036. https://doi.org/10.3324/haematol.2023.284868
  9. Burkhardt B, Michgehl U, Rohde J, Erdmann T, Berning P, Reutter K, Rohde M, Borkhardt A, Burmeister T, Dave S, Tzankov A, Dugas M, et al. Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age. Nat Commun. 2022;13(1):3881.
  10. Thomas N, Dreval K, Gerhard DS, Hilton L K, Abramson J S., et al. Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma. Blood. 2023;141(8): 904-916.  https://doi.org/10.1182/blood.2022016534
  11. Falini B, Lazzi S. Pediatric large B-cell lymphoma with 11q aberration. Blood. 2022; 140 (24): 2644. https://doi.org/10.1182/blood.2022017409
  12. Hare L, Trotman J, Tarpey P, Hook E, Burke GAA. Challenging our understanding of B-cell lymphomagenesis and risk: Paediatric high-grade B-cell lymphoma, not otherwise specified with a DDX3X::MLLT10 fusion and an IGH deletion. Pediatr Blood Cancer. 2024; 71:e30810. https://doi.org/10.1002/pbc.30810
  13. McGowan-Jordan J., Hastings Ros J., Moore S. (eds). An international system for human cytogenetic nomenclature. Karger S., Basel; 2020.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.